Company: CMND
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001213900-25-109567
Chunk: 24

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 24
---
 31, 2025:

| ● | on an actual basis; and |

| ● | on pro forma basis, giving effect to the(issuance of Promissory Notes in the aggregate principal amount of $2.5 million, of which an aggregate of $2.2 million of outstanding amounts due under the Promissory Notes were converted into 4,135,000 Common Shares at conversion prices between $0.412 and $0.818, as if such event had occurred on July 31, 2025 (collectively, the “Pro Forma Adjustments”); and |

| ● | on a pro forma as adjusted basis, to give further effect to the issuance and sale of 3,942,365 Common Shares and/or pre-funded warrants in this offering at a public offering price of $0.20 per Common Share and $0.1999 per pre-funded warrant, after deducting offering expenses payable by us, as if the sale had occurred on July 31, 2025. |

You should read this information
in conjunction with our consolidated financial statements and the related notes appearing at the end of this prospectus and the “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” section and other financial information contained in this
prospectus.

|                                      |     | As of  July 31, 2025 |         |   |     |       |         |   |     |          |         |   |
|:-------------------------------------|:----|:---------------------|--------:|:--|:----|:------|--------:|:--|:----|:---------|--------:|:--|
| U.S. dollars in thousands            |     | Actual               |         |   |     | Pro   
 Forma |         |   |     | Pro      
 Forma As 
 Adjusted |         |   |
| Cash and cash equivalents            |     | $                    |   3,495 |   |     | $     |   5,745 |   |     | $        |   6,483 |   |
| Convertible loan liability           |     |                      |       - |   |     |       |    (254 | ) |     |          |    (254 | ) |
| Derivative warrants liability        |     |                      |  (2,179 | ) |     |       |  (2,179 | ) |     |          |  (2,179 | ) |